Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02333903
Other study ID # RC-P0030
Secondary ID
Status Withdrawn
Phase N/A
First received December 29, 2014
Last updated July 27, 2015
Start date January 2015
Est. completion date July 2017

Study information

Verified date January 2015
Source Lille Catholic University
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

This study compares the ratio of lean mass losses over total body mass losses between patients undergoing sleeve gastrectomy followed by physical activity training versus patients undergoing sleeve gastrectomy only


Description:

This study will assess prospectively and objectively the potential benefits of a personalized and specific rehabilitation program designed for patients who undergone sleeve gastrectomy. This strategy will help to reduce fat mass and to limit lean mass loss, in order to prevent in the short term the overweight recurrence. Also,the improvement of physical and metabolic status is expected.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 2017
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender Female
Age group 25 Years to 45 Years
Eligibility Inclusion Criteria:

- BMI >40 kg/m² or BMI>35kg/m² with comorbidities qualifying for bariatric surgery

- Stable obesity or obesity evolving for more than 5 years

- Patient cleared by the surgeon for sleeve gastrectomy one month before recruitment

- Absence of contraindication for a sub-maximal stress test

- Performance of a polysomnography before surgery

- Signed informed consent

- Patient benefiting from Health Care Coverage

Exclusion Criteria:

- Absence of preliminary and regular medical check-ups mandatory before sleeve gastrectomy

- Anticipated difficulty for patient follow-up

- Mental diseases (psychosis, depression, suicidal behavior or history)

- Eating disorders

- Lack of informed consent or cooperation

- Unsufficient patient commitment

- Patient under judiciary protection

- Patient not able to comply with any or all the research procedures over time including physical activity

- Patient excluded from the french database of volunteers for clinical trials

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Personalized Physical Activity
1.5 hours physical training sessions, twice a week for 1 year, under the supervision of a dedicated coach specialized in supporting overweighted patients. Typical training session organized for small groups (5 patients) will consist of aerobic exercises, muscular strengthening (4 peripheral members and abdominal muscular belt), followed by stretching exercises.

Locations

Country Name City State
France Hopital Saint Philibert Lomme

Sponsors (2)

Lead Sponsor Collaborator
Lille Catholic University Université de Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the ratio of lean mass losses over total body mass losses Percentage of lean mass loss compared to total body weight loss measured with bioimpedancemetry and dual energy X-Rays absorptiometry (DXA) at 1, 6 and 12 months after surgery 1 month, 6 months, 12 months after surgery Yes
Secondary Changes in systolic blood pressure 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the Body Mass Index (BMI) Anthropometric measures to estimate body Mass Index (BMI). 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes in the lipid profile (total cholesterol, LDL HDL, Triglycerides) 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes of glycemia values 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes of HbA1C values 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes of albuminemia values 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes of insulinemia values 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Changes of creatinemia values 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the body composition analysis with segmental analysis Main parameter: Percentage of lean mass loss compared to total body weight loss measured with bioimpedancemetry at at 1, 6 and 12 months after surgery 1 month, 6 months, 12 months after surgery No
Secondary Change in the qualitative evaluation of physical activity. Daily physical activity will be evaluated by a self-questionary (IPAQ) 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the quantitative evaluation of physical activity. Daily physical activity will be evaluated by accelerometer measurements. 1 month, 6 months and 12 months after surgery No
Secondary Sub-maximal stress testing 1 month, 3 months, 6 months, 9 months and 12 months after surgery Yes
Secondary Change in the quantitative evaluation of the sleep quality Comparison of sleep quality : micro awakeness index (average number per hour during Rapid Eye Movement (REM) and Non REM phases); index of micro awakeness following an apnea event. Before and 12 months after surgery No
Secondary Change in the qualitative evaluation of the sleep quality Comparison of the sleep quality by the mean of a visual analogic scale in a sleep diary 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the energy balance Energy balance analysis (energy intake vs energy expenditure) and detailed nutriments analysis. 1 month, 6 months, 12 months after surgery No
Secondary Change in the 6 min Walking test Determination of the maximal walking distance performed by the patient after a 6 minutes walk 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the quantitative self esteem evaluation Rosenberg questionary for the evaluation of Self-esteem 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
Secondary Change in the quantitative evaluation of the health related quality of life Medical Outcome Study Short Form-36 (MOS SF-36) questionary 1 month, 3 months, 6 months, 9 months and 12 months after surgery No
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2